Actively Recruiting
Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
Led by Asan Medical Center · Updated on 2026-02-06
100
Participants Needed
1
Research Sites
159 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of a wearable device in detecting previously undiagnosed atrial fibrillation through non-invasive long-term monitoring using a wearable single-lead ECG patch (MEMO Patch M, MEMO Patch2) in 100 patients with Embolic Stroke of Undetermined Source (ESUS) who require atrial fibrillation screening. Participants who meet all inclusion and exclusion criteria and provide written informed consent will wear the MEMO Patch M and undergo in-hospital telemetry monitoring using MEMO Cue for a minimum of 12 hours and up to 8 days. During hospitalization, 24-hour Holter monitoring will also be conducted. Before discharge, the investigator will review these results to determine whether implantable loop recorder (ILR) implantation is necessary. At the time of discharge, participants will wear MEMO Patch2 for up to 14 days for the first ECG monitoring period. One month after discharge, the investigator will review the results of the first monitoring and initiate the second ECG monitoring with MEMO Patch2. Three months after discharge, the results of the second ECG monitoring will be reviewed, and participation in the clinical trial will be completed.
CONDITIONS
Official Title
Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 years or older who voluntarily provide written informed consent to participate in the study
- Patients diagnosed with Embolic Stroke of Undetermined Source (ESUS)
- Patients who require in-hospital or out-of-hospital electrocardiographic (ECG) monitoring
You will not qualify if you...
- Individuals already diagnosed with atrial fibrillation or atrial flutter
- Individuals with a clearly identified cause of stroke
- Individuals known to have allergic reactions to adhesives or hydrogels
- Individuals who have cognitive vulnerability making it difficult to understand study information and decide on participation
- Any other individuals considered by the principal investigator to be at potential risk or unsuitable for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, Songpa-gu, South Korea, 05505
Actively Recruiting
Research Team
B
Bum Joon Kim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here